Jci_page_head_homepage_01 Jci_page_head_homepage_02
Punita Dhawan, Amar B. Singh, Natasha G. Deane, YiRan No, Sheng-Ru Shiou, Carl Schmidt, John Neff, M. Kay Washington, R. Daniel Beauchamp
Published in Volume 115, Issue 7
J Clin Invest. 2005; 115(7):1765–1776 doi:10.1172/JCI24543
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3

Effects of siRNA-based inhibition of claudin-1 expression in the metastatic SW620 cells. (A) Western blot analysis of SW620 cells stably expressing claudin-1 siRNA (SW620siRNA). Equal amounts of total protein were subjected to immunoblot analysis using anti–claudin-1 antibody. The clones shown were selected based on similar levels of inhibition of claudin-1 expressions. The same lysates were also subjected to immunoblot analysis for claudin-4 to determine the specificity of the siRNA oligonucleotide. Immunoblotting for vimentin, FSP1, and E-cadherin was performed using the same lysates. (B) The upper panel represents immunofluorescence localization of claudin-1, β-catenin, E-cadherin, and vimentin in SW620siRNA cells. Only SW620control cells are shown, as there were no visible differences between SW620control cells and parental SW620 cells. The lower panel represents results of immunoblot analysis using cytosolic and membrane-specific fractions for expressions of β-catenin and E-cadherin in SW620control and SW620siRNA cells. (C) Representative phase-contrast images of monolayer cultures of SW620control, and SW620siRNA cells. (D) Representative photomicrographs of cell migration by monolayer wound-healing assay using SW620control and SW620siRNA clones. Photomicrographs were obtained 0, 24, 48, and 72 hours after standard scrape wounding, as described in Methods.